Neurophysiological Biomarkers of Movement Facilitation in Parkinson’s Disease
Neurophysiological Biomarkers of Movement Facilitation in Parkinson’s Disease
批准号:
10678860
负责人:
Kathryn Amy Cross
金额:
$24.21万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-01 至 2026-08-31
关键词:
AffectAgeAuditoryBasal GangliaBehavioralBiological MarkersBrainCommunitiesComplicationCuesDataDeep Brain StimulationDevelopmentDevelopment PlansDiffusionDiseaseDissociationDorsalElectrocorticogramElectroencephalographyElectrophysiology (science)EnvironmentFailureFreezingFunctional Magnetic Resonance ImagingFutureGaitGlobus PallidusGoalsHeterogeneityImageIncentivesIndependent LivingIndividual DifferencesInjuryKinesisMagnetic Resonance ImagingMapsMeasuresMediatingMentorshipMethodsModalityMotivationMotorMotor outputMovementNeuroanatomyOperative Surgical ProceduresParietalParkinson DiseaseParticipantPathologicPatientsPeriodicityPhysiciansPhysiologyQuality of lifeRefractoryResearchRestRewardsSTN stimulationScientistSensorySeverity of illnessSignal TransductionStimulusSymptomsSystemTechniquesTestingTrainingTranscranial magnetic stimulationVentral StriatumVisualWorkauditory stimulusbehavior measurementbehavior predictionbiomarker identificationcareer developmentclinical movement disordercognitive neurosciencedeep brain stimulatordensityfallsforgingimplantationimprovedinsightkinematicsmotor deficitmotor disordermotor symptomneural networkneuroimagingneuromechanismneurophysiologyneuroregulationneurotransmissionnovelnovel therapeuticsrehabilitation strategyresponseskillsstatisticssymptomatic improvementtherapy developmenttime intervaltractographyvisual motor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
A promising strategy to improve neuromodulation therapies (e.g. deep brain stimulation) in Parkinson’s
Disease (PD) is to develop stimulation paradigms that target specific neural signals. Most previous work has
aimed to identify and reduce pathologic signals. An unexplored alternative approach is to identify and enhance
neural signals that promote movement. Several scenarios known to improve movement in PD patients are the
presence of visual movement targets, rhythmic auditory stimuli, and motivational incentives. The goal of this
proposal is to capitalize on these scenarios to identify biomarkers of movement facilitation that may serve as
targets for future neuromodulation therapies. This approach has potential to provide novel therapies for
symptoms refractory to current treatments, such as freezing of gait. Previous work examining neural
mechanisms of movement facilitation in PD have yielded inconsistent results. This may be due to a failure to
account for well-known heterogeneity in behavioral benefits across PD patients and the assumption that
different cueing phenomena exert motor benefits through a single neural mechanism. The studies proposed
here test the overarching hypothesis that 3 different types of cues (visual targets, rhythmic auditory stimuli and
reward incentives) facilitate movement through distinct neuroanatomic circuits and electrophysiological
mechanisms, by leveraging known variability in behavioral cueing benefits across patients. Aim 1 is to
demonstrate behavioral dissociations between the 3 forms of movement facilitation within patients and relate
variability in cueing benefits to integrity of dissociable neuroanatomic circuits as measured by resting state and
diffusion tensor magnetic resonance imaging (MRI). Aim 2 is to characterize the electrophysiological correlates
of behavioral benefits for the different cue types using electroencephalography (EEG) and intraoperative
electrophysiological recordings obtained during implantation of deep brain stimulator in the globus pallidus
internus. This work will augment my prior skills in task fMRI, transcranial magnetic stimulation (TMS) and
electrophysiology by extending training in multiple modalities (high density EEG, resting state fMRI, DTI); build
my analytic skills in advanced multivariate statistics; and advance my expertise in PD motor physiology. My
mentorship team comprises experts in PD neurophysiology and neuromodulation therapies, and non-invasive
studies of inter-individual differences in motor neurophysiology. Coursework in multivariate statistics and
seminars in advanced EEG and neuroimaging applications will further my development. The environment at
UCLA has a rich interdisciplinary neuroimaging community, state-of-the-art image acquisition facilities including
Ahmanson-Lovelace Brian Mapping Center and Staglin Center for Cognitive Neuroscience and a renowned
clinical Movement Disorders Division. The career development plan forges a path to become an independent
physician-scientist, using multiple modalities to characterize neurophysiologic biomarkers of heterogeneous
disease features in Parkinson’s disease to improve therapy development and delivery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neurophysiological Biomarkers of Movement Facilitation in Parkinson’s Disease
-
批准号:10478191
-
项目类别:
-
资助金额:$24.21万
-
财政年份:2021
-
负责人:Kathryn Amy Cross
-
依托单位:
Neurophysiological Biomarkers of Movement Facilitation in Parkinson’s Disease
-
批准号:10301646
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2021
-
负责人:Kathryn Amy Cross
-
依托单位:
Neural mechanisms of imitative behavior: Implications for mental health
-
批准号:8517816
-
项目类别:
-
资助金额:$4.43万
-
财政年份:2011
-
负责人:Kathryn Amy Cross
-
依托单位:
Neural mechanisms of imitative behavior: Implications for mental health
-
批准号:8411391
-
项目类别:
-
资助金额:$3.31万
-
财政年份:2011
-
负责人:Kathryn Amy Cross
-
依托单位:
Neural mechanisms of imitative behavior: Implications for mental health
-
批准号:8122728
-
项目类别:
-
资助金额:$3.27万
-
财政年份:2011
-
负责人:Kathryn Amy Cross
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: